The Japanese Health System and its coping mechanisms against COVID-19
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2022.181704Keywords:
Japan, Coronavirus infections, Health systems, COVID-19, SARS-CoV2Abstract
Introduction: despite being the country with the highest average age globally, Japan has stood out in the fight against the COVID-19 (Coronavirus Disease 2019) pandemic by presenting low contamination rates by the virus and mortality.
Objective: we aim to discuss the health strategies adopted by Japan in the face of the COVID-19 disease pandemic, as well as to evaluate data on Japanese contamination and mortality compared to the other four countries with the highest average age in the world (Italy, Germany, Portugal and Spain) and Brazil.
Methodology: the search was carried out to evaluate Japanese health strategies by using the following databases: PubMed, Cochrane, and Scielo using a combination of the terms "Japan", "covid", "coronavirus" and "health systems" in English, Spanish and Portuguese. The COVID-19 infection data was extracted from the Our World in Data website, from January 25, 2020, to July 30, 2020.
Results: Among the measures adopted by the country to face the pandemic, the early diagnosis and response to infection, contact tracing, early diagnosis and availability of intensive care for critically ill patients, and encouraging behavioral distancing measures stand out. Among the countries analyzed, Japan has the lowest rates of contamination and mortality in absolute terms by COVID-19.
Conclusions: social distancing measures, early diagnosis, and treatment seem to have contributed to the success in combating COVID-19 in Japan. In the studied period, in a million inhabitants, Japan had 6.13 cases of covid while Brazil had 218.26 cases. As for the number of deaths confirmed by the disease, the first had a rate of 0.23 while the second had 5.16 cases per million inhabitants. Based on the knowledge of these measures, it is possible to seek similar mechanisms when designing health policies to face pandemics in other countries.
Downloads
References
Sakamoto H, Rahman M, Nomura S, Okamoto E, Koike S, Yasunaga H, et al. Japan Health System Review. Health Syst Transit. 2018;8(1):1–228.
Sudo K, Kobayashi J, Noda S, Fukuda Y, Takahashi K. Japan’s healthcare policy for the elderly through the concepts of self-help (Ji-jo), mutual aid (Go-jo), social solidarity care (Kyo-jo), and governmental care (Ko-jo). Biosci Trends. 2018;12(1):7–11.
Bernadette BY, Ruggles M, Xiong AMY, Kyle B. Healthcare coverage in the US and Japan: A comparison. Glob Issues Nurs. 2019;49(4):56–60.
Nomura H, Nakayama T. The Japanese health-care system. BMJ. 2008;44(1):11–3.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81:e16–25.
Houvèssou GM, Souza TP de, Silveira MF da. Medidas de contenção de tipo lockdown para prevenção e controle da COVID-19: estudo ecológico descritivo, com dados da África do Sul, Alemanha, Brasil, Espanha, Estados Unidos, Itália e Nova Zelândia, fevereiro a agosto de 2020. Epidemiol e Serv saude Rev do Sist Unico Saude do Bras. 2021;30(1):e2020513.
Antunes BB de P, Peres IT, Baião FA, Ranzani OT, Bastos LDSL, Silva A de AB da, et al. Progression of confirmed COVID-19 cases after the implementation of control measures. Rev Bras Ter intensiva. 2020;32(2):213–23.
Hallal PC. Worldwide differences in COVID-19-related mortality. Cienc e Saude Coletiva. 2020;25:2403–10.
Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science (80- ). 2020;368(6490):489–93.
Iwasaki A, Grubaugh ND. Why does Japan have so few cases of COVID‐19? EMBO Mol Med. 2020;12(5):10–2.
Legido-Quigley H, Asgari N, Teo YY, Leung GM, Oshitani H, Fukuda K, et al. Are high-performing health systems resilient against the COVID-19 epidemic? Lancet [Internet]. 2020;395(10227):848–50. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30551-1
Machida M, Nakamura I, Saito R, Nakaya T, Hanibuchi T, Takamiya T, et al. Adoption of personal protective measures by ordinary citizens during the COVID-19 outbreak in Japan. Vol. Ahead of p, International Journal of Infectious Diseases. The Author(s); 2020. 139–144 p.
Bezerra ACV, da Silva CEM, Soares FRG, da Silva JAM. Factors associated with people’s behavior in social isolation during the covid-19 pandemic. Cienc e Saude Coletiva. 2020;25:2411–21.
Uchida M, Kaneko M, Hidaka Y, Yamamoto H, Honda T, Takeuchi S, et al. Effectiveness of vaccination and wearing masks on seasonal influenza in Matsumoto City, Japan, in the 2014/2015 season: An observational study among all elementary schoolchildren. Prev Med Reports. 2017;5:86–91.
Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, Chu CC, et al. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet. 2003;4:1–7.
Arts RJW, Moorlag SJCFM, Novakovic B, Li Y, Wang SY, Oosting M, et al. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe. 2018;23(1):89-100.e5.
Otaga M, Morikawa M, Oguchi T, Tamaki Y, Matsushige T, Kumakawa T. Evaluating integrated social care by utilizing regional resources in Japan. Int J Integr Care. 2017;17(5):559.
Castro R, Luz PM, Wakimoto MD, Veloso VG, Grinsztejn B, Perazzo H. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil. Brazilian J Infect Dis. 2020;24(2):180–7.
Zhang ZL, Hou YL, Li DT, Li FZ. Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for COVID-19: A meta-analysis. J Med Virol. 2021;93(1):366–74.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Lucas Soares Bezerra, Maria Mariana Barros Melo da Silveira, Joao Victor Batista Cabral, Maira Galdino da Rocha Pitta, Cesar Augusto Souza de Andrade
This work is licensed under a Creative Commons Attribution 4.0 International License.
